AstraZeneca Agrees To Pay $7.9M For Nexium Kickback Scheme
The large British, Delaware-based pharmaceutical company, AstraZeneca, has agreed to pay the U.S. government $7.9 million in order to resolve claims that it engaged in an illegal kickback scheme with a pharmacy benefits management company involving AstraZeneca’s acid reflux medication, Nexi[...]